Neurotechnology firm BrainScope has named Susan Hertzberg as its new CEO, replacing founder Michael Singer.

Hertzberg most recently served as CEO of Prelude Fertility. She previously served with Quest Diagnostics, Oxford Health Plans and Abbott.

The Bethesda, Maryland devicemaker’s main focus is on developing a handheld, non-invasive device for assessing traumatic brain injuries and concussions.